ZYME Q2 2019 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M-64.2% YoY

Gross Profit

-$16M-201.8% margin

Operating Income

-$29M-373.4% margin

Net Income

-$29M-368.9% margin

EPS (Diluted)

$-0.89

QoQ Revenue Growth

-33.9%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$15M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$415M

Total Liabilities

$81M

Stockholders' Equity

$334M

Cash & Equivalents

$284M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$22M	-64.2%
Gross Profit	-$16M	$7M	-339.8%
Operating Income	-$29M	-$2M	-1359.9%
Net Income	-$29M	-$6M	-395.0%

Revenue Segments

Commercial License Option Exercise

$4M72%

Research Support And Supplies Payments

$1M21%

License and Service

$377,0008%